Cardiovascular Agents Market - Global Professional Analysis and Forecast to 2026

Mar 08, 2020 | 201 PAGES | REPORT CODE: CMM270684

REPORT SUMMARY
TABLE OF CONTENTS
INDUSTRY COVERAGE

The worldwide Cardiovascular Agents market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.8% during the forecast period.

This report presents the market size and development trends by detailing the Cardiovascular Agents market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Cardiovascular Agents market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Cardiovascular Agents industry and will help you to build a panoramic view of the industrial development.

Cardiovascular Agents Market, By Type:

Antianginal Agents
Antiarrhythmic Agents
Inotropic Agents
Miscellaneous Cardiovascular Agents
Peripheral Vasodilators
Renin Inhibitors
Sclerosing Agents
Vasodilators

Cardiovascular Agents Market, By Application:

Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

Some of the leading players are as follows:

Gilead Sciences, Inc.
Boehringer Ingelheim GmbH
Pfizer Inc.
Eli Lilly and Company
Bristol-Myers Squibb Company
Takeda Pharmaceutical Company Limited.
Johnson & Johnson
F. Hoffmann-La Roche Ltd
Bayer AG
Novartis AG
Sanofi
Otsuka Holdings Co., Ltd.
Abbott Laboratories
Astellas Pharma, Inc.
AstraZeneca plc.
Merck & Co., Inc.

Geographically, Major regions are analyzed in details are as follows:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Table of Contents

1 Methodology and Scope

1.1 Market Segmentation & Scope

1.1.1 Technology Type
1.1.2 Product
1.1.3 Application
1.1.4 Regional scope
1.1.5 Estimates and forecast timeline

1.2 Research Methodology
1.3 Information Procurement

1.3.1 Purchased database
1.3.2 Internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research

1.4 Information or Data Analysis

1.4.1 Data analysis models

1.5 Market Formulation & Validation
1.6 Model Details

1.6.1 Commodity flow analysis
1.6.2 Volume price analysis

1.7 List of Secondary Sources
1.8 List of Abbreviations

2 Executive Summary

2.1 Market Outlook
2.2 Segment Outlook

3 Market Variables, Trends, & Scope

3.1 Market Lineage Outlook
3.1.1 Parent market outlook

3.1.2 Ancillary market outlook

3.2 Market Segmentation

3.2.1 Analysis

3.3 Market Dynamics

3.3.1 Market driver analysis
3.3.2 Market restraint analysis
3.3.3 Industry opportunities

3.4 Penetration & Growth Prospect Mapping

3.4.1 Penetration & growth prospect mapping analysis

3.5 Business Environment Analysis Tools

3.5.1 Porter's five forces analysis
3.5.2 PESTLE analysis
3.5.3 Major deals & strategic alliances analysis

4 Cardiovascular Agents Market: Technology Type Analysis

4.1 Cardiovascular Agents Technology Type Market Share Analysis, 2018 & 2026
4.2 Cardiovascular Agents Technology Type Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

4.3.1 Antianginal Agents
4.3.2 Antiarrhythmic Agents
4.3.3 Inotropic Agents
4.3.4 Miscellaneous Cardiovascular Agents
4.3.5 Peripheral Vasodilators
4.3.6 Renin Inhibitors
4.3.7 Sclerosing Agents
4.3.8 Vasodilators

5 Cardiovascular Agents Market: Product Analysis

5.1 Cardiovascular Agents Product Market Share Analysis, 2018 & 2026
5.2 Cardiovascular Agents Product Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Cardiovascular Agents Market: Application Analysis

6.1 Cardiovascular Agents Application Market Share Analysis, 2018 & 2026
6.2 Cardiovascular Agents Application Market: Segment Dashboard
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

6.3.1 Retail Pharmacies
6.3.2 Hospital Pharmacies
6.3.3 Online Pharmacies

7 Cardiovascular Agents Market: Regional Analysis

7.1 Cardiovascular Agents Regional Market Share Analysis, 2018 & 2026
7.2 Cardiovascular Agents Regional Market: Segment Dashboard
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
7.4 List of Players at Regional Level

7.4.1 North America
7.4.2 Europe
7.4.3 Asia Pacific

7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

7.5.1 North America
7.5.2 Europe
7.5.3 Asia Pacific
7.5.4 Latin America
7.5.5 MEA

7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

7.6.1 North America
7.6.2 Europe
7.6.3 Asia Pacific
7.6.4 Latin America
7.6.5 Middle East & Africa

8 Competitive Analysis

8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3 Vendor Landscape

8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

9.1 Gilead Sciences, Inc.

9.1.1 Gilead Sciences, Inc. Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis

9.2 Boehringer Ingelheim GmbH

9.2.1 Boehringer Ingelheim GmbH Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis

9.3 Pfizer Inc.

9.3.1 Pfizer Inc. Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis

9.4 Eli Lilly and Company

9.4.1 Eli Lilly and Company Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis

9.5 Bristol-Myers Squibb Company

9.5.1 Bristol-Myers Squibb Company Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis

9.6 Takeda Pharmaceutical Company Limited.

9.6.1 Takeda Pharmaceutical Company Limited. Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis

9.7 Johnson & Johnson

9.7.1 Johnson & Johnson Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis

9.8 F. Hoffmann-La Roche Ltd

9.8.1 F. Hoffmann-La Roche Ltd Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis

9.9 Bayer AG

9.9.1 Bayer AG Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis

9.10 Novartis AG

9.10.1 Novartis AG Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis

9.11 Sanofi

9.11.1 Sanofi Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis

9.12 Otsuka Holdings Co., Ltd.

9.12.1 Otsuka Holdings Co., Ltd. Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis

9.13 Abbott Laboratories

9.13.1 Abbott Laboratories Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis

9.14 Astellas Pharma, Inc.

9.14.1 Astellas Pharma, Inc. Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis

9.15 AstraZeneca plc.

9.15.1 AstraZeneca plc. Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis

9.16 Merck & Co., Inc.

9.16.1 Merck & Co., Inc. Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis

The List of Tables and Figures (Totals 95 Figures and 121 Tables)

Figure Antianginal Agents Cardiovascular Agents market, 2015 - 2026 (USD Million)
Figure Antiarrhythmic Agents Cardiovascular Agents market, 2015 - 2026 (USD Million)
Figure Inotropic Agents Cardiovascular Agents market, 2015 - 2026 (USD Million)
Figure Miscellaneous Cardiovascular Agents Cardiovascular Agents market, 2015 - 2026 (USD Million)
Figure Peripheral Vasodilators Cardiovascular Agents market, 2015 - 2026 (USD Million)
Figure Renin Inhibitors Cardiovascular Agents market, 2015 - 2026 (USD Million)
Figure Sclerosing Agents Cardiovascular Agents market, 2015 - 2026 (USD Million)
Figure Vasodilators Cardiovascular Agents market, 2015 - 2026 (USD Million)
Figure Retail Pharmacies market, 2015 - 2026 (USD Million)
Figure Hospital Pharmacies market, 2015 - 2026 (USD Million)
Figure Online Pharmacies market, 2015 - 2026 (USD Million)
Table List of players in North America
Table List of players in Europe
Table List of players in Asia Pacific
Table SWOT analysis
Table North America Cardiovascular Agents market, by country, 2015 - 2026 (USD Million)
Table North America Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table North America Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table North America Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table U.S. Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table U.S. Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table U.S. Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Canada Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table Canada Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table Canada Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Europe Cardiovascular Agents market, by country, 2015 - 2026 (USD Million)
Table Europe Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table Europe Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table Europe Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table U.K. Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table U.K. Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table U.K. Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Germany Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table Germany Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table Germany Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table France Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table France Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table France Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Italy Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table Italy Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table Italy Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Spain Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table Spain Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table Spain Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Asia Pacific Cardiovascular Agents market, by country, 2015 - 2026 (USD Million)
Table Asia Pacific Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table Asia Pacific Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table Asia Pacific Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table China Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table China Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table China Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Japan Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table Japan Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table Japan Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table India Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table India Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table India Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Latin America Cardiovascular Agents market, by country, 2015 - 2026 (USD Million)
Table Latin America Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table Latin America Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table Latin America Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Brazil Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table Brazil Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table Brazil Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Mexico Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table Mexico Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table Mexico Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Argentina Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table Argentina Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table Argentina Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table MEA Cardiovascular Agents market, by country, 2015 - 2026 (USD Million)
Table MEA Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table MEA Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table MEA Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table South Africa Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table South Africa Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table South Africa Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Nigeria Cardiovascular Agents market, by type, 2015 - 2026 (USD Million)
Table Nigeria Cardiovascular Agents market, by product, 2015 - 2026 (USD Million)
Table Nigeria Cardiovascular Agents market, by application, 2015 - 2026 (USD Million)
Table Recent Developments & Impact Analysis, by Key Market Participants
Table Recent Developments & Impact Analysis, by Key Market Participants
Table Company market position analysis
Table Company Profiles
Table Gilead Sciences, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Boehringer Ingelheim GmbH Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Eli Lilly and Company Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bristol-Myers Squibb Company Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Takeda Pharmaceutical Company Limited. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table F. Hoffmann-La Roche Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bayer AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Otsuka Holdings Co., Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Astellas Pharma, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AstraZeneca plc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck & Co., Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis

REPORTS

Let’s Pullulate and Expand Your Business

Cardiovascular Agents Market - Global Professional Analysis and Forecast to 2026

Report Purchase